Citation Tools
PDFExtended report
Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?